These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8619576)

  • 1. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.
    Alcaide F; Liñares J; Pallares R; Carratala J; Benitez MA; Gudiol F; Martin R
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2243-7. PubMed ID: 8619576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.
    Liñares J; Alonso T; Pérez JL; Ayats J; Domínguez MA; Pallarés R; Martín R
    J Antimicrob Chemother; 1992 Sep; 30(3):279-88. PubMed ID: 1452492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases.
    Mogi A; Nishi JI; Yoshinaga M; Harada H; Narahara S; Kawakami K; Maruyama I
    Pediatr Infect Dis J; 1997 Dec; 16(12):1140-4. PubMed ID: 9427459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):435-40. PubMed ID: 14522519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococci.
    Thornsberry C; Karlowsky JA; Kelly LJ; Draghi DC; Critchley IA; Jones ME; Sahm DF
    Chemotherapy; 2001; 47(5):332-43. PubMed ID: 11561135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Jan; 41(1):148-55. PubMed ID: 8980771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
    Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
    Hupková H; Trupl J
    Folia Microbiol (Praha); 1998; 43(1):68-70. PubMed ID: 9569631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns.
    Farber BF; Eliopoulos GM; Ward JI; Ruoff KL; Syriopoulou V; Moellering RC
    Antimicrob Agents Chemother; 1983 Nov; 24(5):702-5. PubMed ID: 6607030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
    Vanhoof R; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Nyssen HJ; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
    Acta Clin Belg; 1996; 51(6):377-85. PubMed ID: 8997755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.
    Johnson DM; Doern GV; Haugen TA; Hindler J; Washington JA; Jones RN
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):137-41. PubMed ID: 8902410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci.
    Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Apr; 27(4):151-4. PubMed ID: 9154412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
    Spangler SK; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.